Industry Insights

  1. The Flow State: When Clinical Research Finally Flows 10/17/2025

    When systems align and tools support your work, clinical research enters a flow state — where clarity replaces chaos and progress feels natural, connected, and confidently under control.

  2. Why Asia Should Be Your Next Trial Destination 10/17/2025

    Many U.S. oncology sponsors are expanding their late-phase trials into Asia to secure access to rich patient pools, leverage efficient regulatory pathways, and save time and money in the clinic.

  3. The More We Know, The Better: The Benefits Of EMA Policy 70 10/17/2025

    Get ahead of EMA Policy 70 — start strategic compliance now to balance transparency, protect privacy, and accelerate your path to EU market access.

  4. 100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing 10/17/2025

    Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.

  5. Recruitment Capabilities Delivering In Today's Trial Landscape 10/16/2025

    Clinical trial recruitment now demands diverse capabilities — AI, data analytics, stakeholder engagement, and operational excellence — to meet complex protocols and deliver high-quality patient enrollment outcomes.

  6. eCOA In Oncology Trials: A Tool To Simplify 10/16/2025

    Accurate quality of life data is critical in oncology. eCOA unified with IRT streamlines trials, improves data collection, and enhances site user experiences across therapeutic areas.

  7. Why Real-Time eCOA Data Matters More Than Ever 10/16/2025

    Real-time eCOA data enables faster eligibility decisions, proactive issue alerts, and streamlined operations by unifying data, improving precision, responsiveness, and trial execution efficiency.

  8. What Is Disease Progression Modeling, And When Is The Right Time To Use It? 10/16/2025

    With the help of Clinical Trials Transformation Initiative's Lindsay Kehoe, discover how disease progression modeling can improve trial efficiency, inform precision medicine, assist in regulatory decision-making, and more.

  9. Diverse Enrollment — Ahem, "Biological Variability" — Gets Widespread Support At RAPS Convergence 10/16/2025

    DEI, diverse enrollment, biological variability -- whatever you call it, industry leaders at RAPS Convergence discussed their unwavering support of it when it comes to executing clinical trials that align "good science" with "the right thing to do."

  10. The Immune System's Secret Language: Unlocking Cellular Communication 10/15/2025

    The rising rate of autoimmune conditions requires better ways to monitor cellular activity. See how profiling immune cells by their DNA signatures enables real-time therapeutic insight and prediction.